Clinical Trial Update: Value of Amphotericin B Inhalation for Prophylaxis of Invasive Pulmonary Aspergillosis After Renal Transplantation [Phase 4]

View source ↗

Summary

This update covers a Phase 4 trial evaluating inhaled amphotericin B for preventing invasive pulmonary aspergillosis in kidney transplant recipients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Invasive Pulmonary Aspergillosis

Drugs mentioned

• Amphotericin B inhalation (amphotericin B inhalation)

Snippet

Sponsor: Capital Medical University | Conditions: Invasive Pulmonary Aspergillosis | Phase 4 | Status: UNKNOWN